Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer.
Stereotactic body radiotherapy is an emerging treatment option for peripheral non-small cell lung cancer in medically inoperable patients. With high dose per fraction radiotherapy, late side effects are of possible concern. In our initial cohort of 42 patients treated with 54 to 60 Gy in three fractions, nine patients have rib fracture. The median dose to rib fracture sites was 46 to 50 Gy, depending on the method of dose calculation. We describe a typical case of poststereotactic radiotherapy rib fracture and present dosimetric analysis of patients with rib fracture.
Voroney
Jon-Paul J
JP
Department of Radiation Oncology, Tom Baker Cancer Centre Alberta, Canada. jonpaulv@cancerboard.ab.ca
Hope
Andrew
A
Dahele
Max R
MR
Purdie
Thomas G
TG
Purdy
Thomas
T
Franks
Kevin N
KN
Pearson
Shannon
S
Cho
John B C
JB
Sun
Alex
A
Payne
David G
DG
Bissonnette
Jean-Pierre
JP
Bezjak
Andrea
A
Brade
Anthony M
AM
D000369:Aged, 80 and over; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology / Q000601:surgery*; D002637:Chest Pain / Q000209:etiology* / Q000628:therapy; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000601:surgery*; D008297:Male; D016634:Radiosurgery / Q000009:adverse effects*; D012253:Rib Fractures / Q000209:etiology* / Q000628:therapy; D014057:Tomography, X-Ray Computed